Jack Lawler
Chief Tech/Sci/R&D Officer at CHEMOMAB THERAPEUTICS LTD.
Profile
Jack Lawler is currently the VP-Global Clinical Development Operations at Chemomab Therapeutics Ltd.
He previously worked as the VP-Clinical Operations & Data Management at Goldfinch Bio, Inc. Mr. Lawler completed his undergraduate degree at Rosemont College.
Jack Lawler active positions
| Companies | Position | Start |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 03/01/2022 |
Former positions of Jack Lawler
| Companies | Position | End |
|---|---|---|
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Jack Lawler
| Rosemont College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Jack Lawler
